![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2009 by The American Society for Cell Biology Subtelomeric ACS-containing Proto-silencers Act as Antisilencers in Replication Factors Mutants in Saccharomyces cerevisiae *Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada; and †Laboratoire de Biologie Moléculaire de la Cellule de l'Ecole Normale Supérieure de Lyon, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5161, F-69364, Lyon, France Yixian Zheng, Monitoring Editor Corresponding author.Address correspondence to: Krassimir Yankulov (Email: yankulov/at/uoguelph.ca) Received February 8, 2008; Revised October 1, 2008; Accepted November 4, 2008. Abstract Subtelomeric genes are either fully active or completely repressed and can switch their state about once per 20 generations. This meta-stable telomeric position effect is mediated by strong repression signals emitted by the telomere and relayed/enhanced by weaker repressor elements called proto-silencers. In addition, subtelomeric regions contain sequences with chromatin partitioning and antisilencing activities referred to as subtelomeric antisilencing regions. Using extensive mutational analysis of subtelomeric elements, we show that ARS consensus sequence (ACS)-containing proto-silencers convert to antisilencers in several replication factor mutants. We point out the significance of the B1 auxiliary sequence next to ACS in mediating these effects. In contrast, an origin-derived ACS does not convert to antisilencer in mutants and its B1 element has little bearing on silencing. These results are specific for the analyzed ACS and in addition to the effects of each mutation (relative to wild type) on global silencing. Another line of experiments shows that Mcm5p possesses antisilencing activity and is recruited to telomeres in an ACS-dependent manner. Mcm5p persists at this location at the late stages of S phase. We propose that telomeric ACS are not static proto-silencers but conduct finely tuned silencing and antisilencing activities mediated by ACS-bound factors. INTRODUCTION Genes positioned close to telomeres are either fully active or completely repressed. They switch their state of expression once per 20 generations on average. This meta-stable telomeric position effect (TPE) is governed by strong repression signals emitted by the telomeres (Fourel et al., 2002a ; Tham and Zakian, 2002 ; Rusche et al., 2003 ). Weaker repressor elements in the core X- and Y′-subtelomeric elements, called proto-silencers, can relay and enhance repression signals away from telomeres (Fourel et al., 2002a ). To date, proto-silencer activity has been demonstrated for ARS consensus sites (ACS) and for the binding sites for Rap1p and Abf1p (Boscheron et al., 1996 ; Fourel et al., 1999 ; Pryde and Louis, 1999 ; Lebrun et al., 2001 ). In addition, subtelomeric core X- and Y′-elements contain sequences, which display chromatin partitioning or antisilencing activities and are referred to as subtelomeric antisilencing regions (STARS) (Fourel et al., 1999 , 2004 ; Pryde and Louis, 1999 ). The state of gene expression at individual telomeres is determined by the complex interplay between the telomere, proto-silencers, and antisilencers (Fourel et al., 1999 ; Pryde and Louis, 1999 ; Lebrun et al., 2001 ; Fourel et al., 2002a , 2004 ; Rehman et al., 2006 ); however, it is not clear whether and how these elements contribute to the variegated nature of TPE.ACS is a conserved 11-base pair sequence found in all yeast origins of replication, in subtelomeric core X- and Y′-elements and in the silencers of the mating type loci. ACS binds origin recognition complex (ORC) and is essential for replication initiation at origins and for silencing at the mating type loci (Bell and Stillman, 1992 ; Diffley and Cocker, 1992 ; Rusche et al., 2003 ). A less conserved B1 element upstream of ACS serves as an additional docking site for ORC and contributes to, but is not essential for replication initiation (Marahrens and Stillman, 1992 ; Rao and Stillman, 1995 ; Lee and Bell, 1997 ). The B1 element of the HMR-E silencer is dissimilar to the B1 elements found in origins (Palacios DeBeer and Fox, 1999 ; Palacios DeBeer et al., 2003 ). It confers high affinity to ORC and contributes to robust silencing of HMR (Palacios DeBeer and Fox, 1999 ; Palacios DeBeer et al., 2003 ). The role of B1 and ACS in subtelomeric core X- and Y′-elements has not been addressed.TPE is modulated by a significant number of genes. For example, mutations in general regulators of silencing such as the SIR genes, in the ORC genes, ABF1 and RAP1, reduce the silencing at telomeres, the mating type loci and at the ribosomal gene loci (Aparicio et al., 1991 ; Pryde and Louis, 1999 ; Roy and Runge, 2000 ). In contrast, genes involved in telomere maintenance and localization (HDF1, HDF2, MRE11, XRS2, and RAD50) specifically affect silencing at telomeres (Boulton and Jackson, 1998 ; Laroche et al., 1998 ; Fisher and Zakian, 2005 ; Mueller et al., 2006 ). Finally, the histone methylase COMPASS (Mueller et al., 2006 ), the histone acetyl transferase NuA4 (Babiarz et al., 2006 ; Clarke et al., 2006 ), the histone chaperone CAF-1 (Mueller et al., 2006 ; Tamburini et al., 2006 ), cohesin (Suter et al., 2004 ; Chang et al., 2005 ), SUM1 (Irlbacher et al., 2005 ), and SCP160 (Marsellach et al., 2006 ) were also implicated in telomeric silencing.There is a puzzling link between DNA replication and silencing. The establishment of silent chromatin requires the passage through S-phase (Miller and Nasmyth, 1984 ), but does not require DNA replication per se (Dubey et al., 1991 ; Kirchmaier and Rine, 2001 ; Li et al., 2001 ). Even so, many genes that affect silencing encode DNA replication factors. These include ORC2, ORC5, MCM5, MCM10, CDC44, CDC45, POL30 (Ehrenhofer-Murray et al., 1995 ; Dillin and Rine, 1997 ; Fox et al., 1997 ; Ehrenhofer-Murray et al., 1999 ; Dziak et al., 2003 ; Suter et al., 2004 ; Liachko and Tye, 2005 ). Paradoxically, an earlier comprehensive study on telomeric silencing found that mutations in orc2 and orc5 have little effect on gene expression in the vicinity of ACS (Pryde and Louis, 1999 ). Similarly, the deletion of ACS in the HMR-E silencer actually increased HMR repression in orc2 mutants (Palacios DeBeer and Fox, 1999 ). On the other hand, we have demonstrated that mutations in orc2, orc5 and mcm5 exert their effects on subtelomeric silencing mostly via ACS (Rehman et al., 2006 ). In an attempt to resolve this apparent inconsistency on the role of ACS in silencing, we further explored the ACS-mediated effects in different mutants. Intriguingly, we noticed that in certain mutants the subtelomeric ACS alter their behavior and act as antisilencers.MATERIALS AND METHODS Yeast Strains and Reporter Constructs The yeast strains used are shown in Supplemental Table 1. All experiments were performed at the permissive temperature of 23°C. The constructs used are shown in Figure 1 ; GF100 in (Fourel et al., 2002b ); URA3-tel and URA3-UASGAL4-tel in (Jacobson and Pillus, 2004 ), ARS1-URA3-tel, and URA3-ARS1-tel in (Rehman et al., 2006 ). GF6(ACS−), GF44(ACS−), GF6(B1−), GF44(B1−), ARS1(ACS−)-URA3-tel, ARS1(B1−)-URA3-tel, and URA3-ARS1(B1−)-tel were generated by site-directed mutagenesis of GF6, GF44, ARS1-URA3-tel, and URA3-ARS1-tel as depicted in Figure 1
GAL4DBD-Fusion Protein Expression Cassettes The coding sequence of ORC1, ORC2, and MCM3 were produced by polymerase chain reaction (PCR) of genomic DNA from W303. MCM5 was produced by PCR from pIP122CDC46 (Gauthier et al., 2002 ). The mcm5-461 and mcm5-1 alleles were produced by PCR with genomic DNA from the corresponding strains in Supplemental Table 1. All fragments were cloned into pGBKT7 to produce GAL4DBD fusion cassettes and then subcloned in pRS315 (CEN4, ARS1, LEU2). pGAL4DBD-GCN5, pGAL4DBD-SIR1 and pGAL4DBD-MCM10 have been described in Jacobson and Pillus (2004) and Liachko and Tye (2005) , respectively. The expression plasmids were transformed into cells with previously integrated URA3-tel, URA3-UASGAL4-tel, or GF100 constructs.Reporter Activity Assays URA3 expression renders the cells sensitive to fluoroorotic acid (FOA). Hence, the proportion of cells with repressed URA3 was assessed as percentage of FOA resistant cells (%FOAR). The proportion of cells expressing TRP1 in the GF100 construct was assessed by growth on SC-trp plates. For the selection of the GAL4DBD-fusion protein expression plasmids, additional nutrients (leucine or histidine) were omitted as appropriate. For each measurement, three colonies were grown in nonselective (YPD) medium for 20–30 generations. Serial 1:10 dilutions from each individual culture were spotted on SC, SC/FOA, or SC-trp plates as appropriate. The %FOAR or %TRP+ was calculated as the average number of colonies on SC/FOA or SC-trp plates divided by the average number of colonies on SC plates. The average values ± SE (calculated in Excel; Microsoft, Redmond, WA) of n triplicate measurements were then calculated and are shown in Supplemental Tables 2–6. Chromatin Immunoprecipitation (ChIP) Cells were arrested in mitosis by 12 μg/ml nocodazole and released from the block as described in Rehman et al. (2006) . Samples of 50 ml were cross-linked at the time points indicated in text. Cross-linking was as in Kurdistani and Grunstein (2003) with modifications. Briefly, 50-ml cultures at OD600 = 1.2 were suspended in 20 ml of PBS/10 mM dimethyl adipimidate for 15 min at 25°C, and then 30 ml of PBS/1.6% formaldehyde was added for 25 min. After quenching with glycine cells were suspended in 2.5 ml of LIP (Lysis/IP) buffer (50 mM Tris-HCl, 140 mM NaCl, 3 mM EDTA, 1× protease inhibitor cocktail (P8215; Sigma-Aldrich, St. Louis, MO) and broken with glass beads. Chromatin and cell debris were collected by spinning, suspended in LIP and sonicated for 12 min in Bioruptor (Diagenode, Liege, Belgium) at maximum output. Debris was removed by spinning, and an aliquot was uncross-linked to confirm an average size of DNA of 500 base pairs. The samples received Triton X-100 and Na-deoxycholic acid to 0.5 and 0.05%, and then they were immunoprecipitated with 10 μg of anti-MCM5 (Sc-6680; Santa Cruz Biotechnology, Santa Cruz, CA) antibody for 3 h. Load, wash and eluate samples were uncross-linked and analyzed by PCR with primers specific for ARS1, ARS305, ARS501, and core X. Core X signals were also confirmed by slot-blot. The primers for the core X element in GF44 and GF44(ACS−) anneal to the plasmid backbone of the integrating constructs and do not amplify genomic core X. Primer sequences are available upon request.RESULTS Experimental Strategy Recently, we correlated the telomeric antisilencing defects of several mutants (mcm5-461, orc2-1, orc5-1, and cdc45-1) to the presence of ACS (Rehman et al., 2006 ). These mutations significantly weaken telomeric silencing (see Supplemental Tables 2 and 3), whereas the deletion of ACS diminished these effects (Rehman et al., 2006 ). A separate study has shown that deletion of sas2 also requires intact ACS for its effect on silencing (Ehrenhofer-Murray et al., 1997 ). cdc7-1 displays both ACS-dependent and ACS-independent effects (Rehman et al., 2006 ). cdc6-1 and Δsir2 reduced silencing independently of ACS (Ramachandran et al., 2006 ; Rehman et al., 2006 ).In the current study, we present extensive mutational analyses of ACS and the auxiliary B1 element in these mutant strains. Two well characterized constructs, GF6 and GF44 (Fourel et al., 1999 ; Rehman et al., 2006 ), contain a conserved subtelomeric core X elements plus a STAR element and a URA3 reporter (Figure 1 ) contain the 150-base pair genomic sequence encompassing the ARS1 origin of DNA replication (Figure 1The ACS- and B1-mutations in core X and in ARS1 are depicted in Figure 1 ; Rao and Stillman, 1995 ). In our constructs, we have substituted AAA with CCC or CGC so we expect these substitutions to preclude the binding to ORC and any effects associated with ACS. The neighboring B1 element is loosely conserved (Palacios DeBeer et al., 2003 ) with AWnY forming its core (Figure 1 ; Lee and Bell, 1997 ). In ARS1, single mutations in AW (A839A840) (Rao and Stillman, 1995 ) reduced but did not abolish binding to ORC and also decreased the stability of ARS1-harboring minichromosomes. Total replacement of B1 by a linker did not produce stronger effects. In HMR-E, substitutions in B1 reduced its affinity to ORC and converted it to a poor silencer but a good origin of replication (Palacios DeBeer et al., 2003 ). We have mutated the AW doublets in ARS1 and core X to CC. We expect these mutations to decrease, but not abolish, the binding to ORC. In terms of function, we expect the mutations to preclude any effects mediated by B1.All mutant and wild-type constructs were integrated at the same position in VII-L telomere of mcm5-461, orc2-1, orc5-1, cdc45-1, Δsas2 cdc6-1, cdc7-1, and Δsir2 or the corresponding wild-type strains MCM5 and W303. Three colonies (per experiment) were streaked on SC-ura and SC/FOA plates to confirm variegated expression and then grown for 30 generations in YPD medium to allow for telomeric expression equilibrium to be reached under nonselective conditions. The %FOAR for the three colonies was assessed by the FOAR reporter activity assay and then average %FOAR and errors for (n) independent triplicate experiments were calculated (Supplemental Tables 2 and 4). Finally, we divided the average %FOAR value in the (ACS−) and (B1−) constructs where the effects of ACS are abolished, by the average %FOAR value in the constructs with intact B1/ACS elements (Figures 2
Silencing Effects of ACS We used the ACS−/ACS ratios for the ARS1-URA-tel, GF44, and GF6 constructs to specifically assess the silencing effects of ACS in each individual mutant. As expected, in all three constructs the ablation of ACS decreased the silencing of URA3 in the MCM5 and W303 strains by 2- to 4-fold, thus reiterating that in wild-type context ACS acts as a proto-silencer (Figure 2 ,b ). The other three mutants had similar effects on GF44 and GF6. We concluded that in mcm5-461, orc2-1, orc5-1, and cdc45-1 the core X-ACS displayed properties typical for an antisilencer (Figure 2We considered that this surprising behavior of ACS in the mutants could be a nonspecific effect of overall reduction in silencing. For this reason, we performed similar assays in four other mutants. As mentioned, Δsas2 requires intact ACS for its effect (Ehrenhofer-Murray et al., 1997 ), cdc7-1 has both ACS-dependent and ACS-independent effects (Rehman et al., 2006 ), whereas cdc6-1 and Δsir2 act independently of ACS (Ramachandran et al., 2006 ; Rehman et al., 2006 ). As expected, in Δsas2 cells the destruction of ACS exacerbated the loss of silencing in all three constructs albeit to a different level compared with wild-type cells (Figure 2Finally, we tested whether the observed effects of the core X-ACS element could somehow be driven by the neighboring STAR element. In Figure 2 Silencing Effects of B1 At least two studies have reported functional dissimilarities between different B1 elements that relate to the replicator or silencer efficiency (Palacios DeBeer and Fox, 1999 ; Palacios DeBeer et al., 2003 ; Chang et al., 2008 ). We therefore asked whether the apparent differences of ACS in ARS1 and core X could be extended to their B1 elements. We mutated the B1 elements in the ARS1-URA-tel, URA-ARS1-tel, GF44, and GF6 and used the B1−/B1 ratios to evaluate the contribution of B1 to telomeric silencing. The destruction of B1 in ARS1 only marginally affected silencing in the mutants and actually slightly increased repression in the wild-type strains (Figure 3The significance of the data presented in Figures 2 Mcm5p Has Antisilencing Activity The conversion of coreX-B1/ACS from proto-silencer to antisilencer suggests that a hypothetic ACS-binding antisilencing factor could be more active in the analyzed mutants. This idea prompted us to look for possible antisilencing activities in transfactors, which are known to associate with ACS. We exploited an assay, which has been extensively used to identify general antisilencing activities out of the context of ACS or other silencers (Fourel et al., 1999 , 2002b , 2004 ; Jacobson and Pillus, 2004 ; Liachko and Tye, 2005 ). It measures the expression of reporters inserted in the VII-L telomere upon the tethering of recombinant GAL4-fusion proteins via a nearby UASGAL1-10 site (Figure 4 ) (see Supplemental Figure 1 for details on these mutations), mcm5(bob1-1)(Hardy et al., 1997 ), MCM10, mcm10-1 (Liachko and Tye, 2005 ), and SIR1 alleles, respectively, were fused to a GAL4DBD expression cassette and subcloned in low copy plasmids (pRS315). The produced plasmids were then transformed into a wild-type (W303) strain containing the URA3-UASGAL-tel reporter inserted in the VII-L telomere (Jacobson and Pillus, 2004 ). The expression of the recombinant proteins was confirmed by Western blot with anti-GAL4 antibodies (data not shown). Next, using the FOAR assay, we evaluated how these proteins influenced the repression of URA3 (Figure 4In tune with several previous reports (Rusche et al., 2003 ; Liachko and Tye, 2005 ), the tethering of Orc1p, Orc2p, Sir1p, Mcm10p, and the mutant Mcm10-1p increased the repression (albeit at different levels) at the VII-L telomere relative to GAL4DBD alone. However, Mcm5p or the mutant Mcm5-461p and Mcm5-1p proteins displayed distinct antisilencing activity. The mutations in Mcm5-461p and Mcm5-1p only moderately reduced the antisilencing effect of the wild-type protein (Figure 4 ), we speculate that the antisilencing activity of Mcm5p is at least partially regulated by CDC7. Another member of the MCM family, Mcm3p, showed silencing rather than antisilencing properties (Figure 4We tested whether the antisilencing activity of the Mcm5p proteins was due to side effects of overexpression not mediated by the UASGAL4 site. In Figure 4 ) relative to GAL4DBD alone, whereas the mutant proteins had weaker effects. GAL4-Orc1p also reduced repression by approximately threefold. However, the ratio %FOAR(URA3-UASGAL-tel)/FOAR(URA-tel) indicated that the antisilencing effect of the Mcm5 proteins is 80–90 times stronger on the URA3-UASGAL-tel cassette (LPY1030; Jacobson and Pillus, 2004 ), whereas Orc1p increased silencing by approximately twofold (Figure 4Next, we asked what could be the mechanism, which is engaged in this antisilencing activity of Mcm5p. We performed similar tethering assays in strains with deletions in four nonessential histone-acetyl-transferase genes: Δhat1, Δgcn5, Δsas2, and Δsas3 (Figure 4 Mcm5 Is a Poor Chromatin Insulator Certain proteins or DNA elements impede the spreading of chromatin modifications into adjacent genomic domains thus acting as chromatin insulators or “partitioners” (Fourel et al., 2002b , 2004 ; Ishii et al., 2002 ). We considered the possibility that the observed effects of the Mcm5 proteins are a consequence of chromatin partitioning rather than of genuine antisilencing. We addressed this issue in the GF100 strain (Figure 5 ), which harbors a double reporter cassette (URA3 and TRP1) and a STAR element inserted in the VII-L telomere. These two reporters are separated by UASGAL so that TRP1 is proximal to the telomeric repeats. If a protein tethered to UASGAL4 equally increases or decreases the levels of expression of TRP1 and URA3, then this protein has antisilencing or silencing activities only. However, if the tethered protein increases the levels of expression of TRP1 and URA3 remains repressed, it acts as a chromatin insulator (Fourel et al., 2002b , 2004 ). In this assay, the level of repression of URA3 is assessed as %FOAR cells, the level of repression of TRP1 is assessed as %TRP+ cells, whereas partitioning activity is assessed as %FOAR&TRP+ cells.
Using the GF100 strain, the three GAL4-Mcm5 proteins were compared with GAL4DBD and to well characterized silencing (GAL4-Orc2p) (Rusche et al., 2003 ) or antisilencing (GAL4-Gcn5p) (Jacobson and Pillus, 2004 ) proteins. As expected, GAL4-Orc2p increased the %FOAR cells and decreased the %TRP+ cells, whereas GAL4-Gcn5p had the opposite effect relative to GAL4DBD alone (Figure 5Because Mcm5p and Gcn5p induce significant levels of derepression at the VII-L telomere and as a result low % FOAR cells, it may be difficult to detect partitioning activity under these experimental conditions. We addressed this concern by deleting RIF1 in the GF100 strain (Fourel et al., 2002b ). RIF1 counteracts the repression signals emitted by the telomere via Rap1p (Fourel et al., 2002b ). Indeed, the deletion of RIF1 increased ~10 times the repression of both URA3 and TRP1 (Figure 5Mcm5p Remains Associated with Core X in Late S Phase Prior studies have shown abundant association of MCM proteins with subtelomeric regions (Wyrick et al., 2001 ), but it is not known whether this abundance is dependent on subtelomeric ACS. We tested whether this is the case. We conducted ChIP with anti-Mcm5p antibodies in W303 strains harboring the GF44 or GF44(ACS−) constructs in the VII-L telomere. After determining the linear range for PCR in input samples (data not shown), the input and immuno-enriched DNA was quantified by PCR with primers for ACT1, ARS305, ARS501, total genomic core X, and the core X element in the VII-L telomere in GF44. The signals from the eluates relative to input in the W303 and W303/GF44 strains are plotted in Figure 6
Next, we analyzed the subtelomeric occupancy by Mcm5p in two mutants, which display strong ACS-dependent antisilencing activity, orc2-1 and orc5-1. Wild-type (W303) and mutant cells were arrested in mitosis by nocodazole for 3 h and then washed and suspended in YPD. Samples were collected at 10, 35, 60, and 75 min after release from the point of mitotic arrest. These time points correspond to early G1, late G1/S, S, and late S/G2 phases of the cell cycle, respectively (Rehman et al., 2006 ). The cells were cross-linked, lysed, and chromatin was immunoprecipitated with anti-Mcm5p antibodies. The association of Mcm5p with a very early (ARS305), an early (ARS1), and a late (ARS501) origins as well as with core X DNA was measured by PCR and is plotted in Figure 6 ). The Mcm5p association markedly diminishes in the subsequent time points at the two early origins (Figure 6 ). Remarkably, ChIP signals with core X-DNA were quite dissimilar compared with the pattern displayed by the origins (Figure 6 ). Although we do not favor the idea, our data do not exclude a continuous loading of MCMs at telomeres through S-phase or enrichment of MCMs via arriving replication forks. In any case we can make the minimal conclusion that considerable amounts of Mcm5p are present at telomeres through the late stages of S phase. Regardless of the mechanism, this pattern is in stark contrast to the loading and displacement of MCM proteins at origins (Figure 6 ), providing opportunity for longer action of the antisilencing activity of Mcm5p.DISCUSSION Subtelomeric ACS Convert to Antisilencers in Replication Factors Mutants ACS represents the essential core of all origins of DNA replication (Breier et al., 2004 ) and of the silencers at the mating type loci (Rusche et al., 2003 ). At telomeres, ACS operate as weaker proto-silencers, which relay/enhance the repression signals emitted by the telomere, whereas their destruction causes modest decrease in silencing (Fourel et al., 2002a ). At telomeres, we also find other regulatory units such as antisilencers and chromatin insulators (Fourel et al., 2004 ). A peculiar feature of gene expression at telomeres is its metastable character, meaning that subtelomeric genes switch at low frequency from complete repression to full expression (Rusche et al., 2003 ). It is not clear how this meta-stability persists and why the combination of a strong silencer (the telomere) and proto-silencers (ACS, Abf1p-, and Rap1p-binding sites) can successfully establish, but then fail to maintain the repressed state. One can speculate that some of these repressor elements temporarily reduce their strength or alternatively, antisilencer elements temporary increase their activity to allow for the reversal.In this article, we analyze the role of ACS in telomeric silencing and show that their destruction increases repression in orc2-1, orc5-1, mcm5-461, and cdc45-1 mutants (Figure 2 Are the reported effects indeed mediated by ACS? First, we point out that the observed conversion cannot be a mere consequence of global derepression in the mutants. For example, the cdc6-1, cdc7-1, and Δsir2 mutations caused significant reduction in telomeric silencing (Ramachandran et al., 2006 ; Rehman et al., 2006 ) but did not alter the nature of ACS (Figure 2 ; Pryde and Louis, 1999 ; Lebrun et al., 2001 ; Fourel et al., 2002b ) have observed very strong de-repression uncharacteristic for other mutants. Hence, we do not exclude the possibility that the strong effects in Figure 2A very recent article (Chang et al., 2008 ) mapped the essential replication activity of HMR-E to two overlapping 9/11 ACS matches, but not to the 11/11 ACS match of the silencer (ARS317). Is it then possible that the antisilencing activity at telomeres is mediated by near-ACS matches? We see no such overlapping near-ACS matches at the telomere whereas the individual near-ACS matches are eight of 11 at best. At the same time, mutation of the B1 site next to the 11/11 ACS match did not have strong effect on the replication activity of HMR-E (ARS317) and the subtelomeric ARS319 (Chang et al., 2008 ) but have profound effect on silencing at HMR-E (Palacios DeBeer et al., 2003 ) and at the telomere (our findings). These observations provide circumstantial support to the notion that the B1/ACS element rather than near-ACS matches are responsible for the silencing effects at these positions.The conclusion that subtelomeric ACS act as an antisilencers in certain replication factor mutants challenges many earlier studies, which consistently portray ACS as silencers or proto-silencers (Fourel et al., 2002a ; Rusche et al., 2003 ). Yet, our observations do not stand alone. A systematic study on the silencing of a reporter along the VII-L subtelomere has paradoxically shown that orc2-1 and orc5-1 cause significant derepression at most subtelomeric positions but have almost no effect in the vicinity of ACS (Pryde and Louis, 1999 ). In addition, similarly to the data presented here, the destruction of ACS in the HMR-E silencer in orc2-1 actually increased repression (Palacios DeBeer and Fox, 1999 ). We extend these observations and propose that subtelomeric ACS have weak and/or short-lived antisilencing activity, which is somehow revealed in replication factor mutants.Functional Differences between Subtelomeric and Origin B1/ACS In Figures 2 ; Rao and Stillman, 1995 ). Incontrast, mutations in B1of HMR-E make this element a poor silencer but a good origin (Palacios DeBeer and Fox, 1999 ; Palacios DeBeer et al., 2003 ). Furthermore, the silencing, but not the replication strength of several B1/ACS combinations was correlated to their high affinity to ORC (Palacios DeBeer et al., 2003 ).It is important that the B1 elements of core X (Figure 3 ) but not B1 in ARS1 (Figure 2 ). We anticipate the coreX-B1/ACS element to have high-affinity to ORC. Notwithstanding the affinity to ORC, it seems that B1 elements can distinguish between replicator and silencer types of ACS. There are ~10,000 ACS matches or near matches in the yeast genome (Breier et al., 2004 ), but only a few hundred of them have been functionally assigned as origins and only several as silencers/proto-silencers. We propose that the adjacent B1 elements can predict the functions of ACS, which are not experimentally accessible at the threshold of genome-wide studies.How Can ACS Be Proto-Silencer and Antisilencer? Many of the proteins, which work in both replication and silencing, bind ACS or regulate the action of ACS-bound proteins (Rusche et al., 2003 ). In DNA replication, ACS is a focal point of a rigorously regulated protein complex, which controls origin licensing and firing (Rusche et al., 2003 ). It would be surprising if the same ACS-bound proteins in core X are spared from similar control and do not undergo modifications during G1 and S phases. At this point, it is not clear how B1 elements (and affinity to ORC) affect these modifications. Still, it is possible that such modifications temporarily unleash antirepression activity to balance the repression signals emitted by other ACS-bound factors. In tune with this idea, we have observed that mutations in CDC7 (a protein kinase) modulate the silencing properties of proteins tethered to the telomere (Supplemental Figure 2). If alterations in ACS-bound proteins can temporarily convert these complexes to antisilencers, then mutations in them can unduly unleash antisilencing or, being also mutations in replication factor, can simply extend S phase thus prolonging the time of the ACS-driven antirepression. The net effect will lead to the observations in Figure 3Is Mcm5p an Antisilencing Module on ACS-bound Complexes? We show that the Mcm5p is as strong antisilencer as the histone acetyl transferase Gcn5p, whereas other ACS associating proteins (Orc1p, Orc2p, Mcm3p, and Mcm10p) are silencers (Figures 4 ; Jacobson and Pillus, 2004 ; Liachko and Tye, 2005 ). It is noteworthy that the antisilencing activity of Mcm5p is dependent on GCN5 and HAT1 (Figure 4Equally importantly, we show that unlike origins of replication, core X associates with Mcm5p later in S phase (Figure 6 ). We postulate that the mcm5-461, mcm5-1, and other mutations probably boost antisilencing by prolonging S phase (Rehman et al., 2006 ) rather than by affecting the Mcm5p antisilencing activity itself.In conclusion, we propose that there is a dynamic interplay of weak antirepression (Mcm5p) and stronger repression (Orc1p, Orc2p, Mcm3p, and Mcm10p) signals on telomeric ACS. Mutations, which prolong the time of manifestation or boost these antisilencing activities by other means can in turn convert ACS from proto-silencers to antisilencers. [Supplemental Materials]
ACKNOWLEDGMENTS We thank J. Rine, B. Stillman, S. Jacobson and I. Liachko for the generous donation of strains and plasmids. This study was supported by a grant from Natural Ssciences Engineering and Research Council-Canada (to K. Y.) and a grant from the Ligue Nationale Contree le Cancer-France (to E. G.). Abbreviations used: Footnotes This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E08-01-0099) on November 12, 2008. REFERENCES
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Bioessays. 2002 Sep; 24(9):828-35.
[Bioessays. 2002]Oncogene. 2002 Jan 21; 21(4):512-21.
[Oncogene. 2002]Annu Rev Biochem. 2003; 72():481-516.
[Annu Rev Biochem. 2003]EMBO J. 1996 May 1; 15(9):2184-95.
[EMBO J. 1996]EMBO J. 1999 May 4; 18(9):2522-37.
[EMBO J. 1999]Nature. 1992 May 14; 357(6374):128-34.
[Nature. 1992]Nature. 1992 May 14; 357(6374):169-72.
[Nature. 1992]Annu Rev Biochem. 2003; 72():481-516.
[Annu Rev Biochem. 2003]Science. 1992 Feb 14; 255(5046):817-23.
[Science. 1992]Proc Natl Acad Sci U S A. 1995 Mar 14; 92(6):2224-8.
[Proc Natl Acad Sci U S A. 1995]Cell. 1991 Sep 20; 66(6):1279-87.
[Cell. 1991]EMBO J. 1999 May 4; 18(9):2538-50.
[EMBO J. 1999]Curr Biol. 2000 Jan 27; 10(2):111-4.
[Curr Biol. 2000]EMBO J. 1998 Mar 16; 17(6):1819-28.
[EMBO J. 1998]Curr Biol. 1998 May 21; 8(11):653-6.
[Curr Biol. 1998]Nature. 1984 Nov 15-21; 312(5991):247-51.
[Nature. 1984]Mol Cell Biol. 1991 Oct; 11(10):5346-55.
[Mol Cell Biol. 1991]Science. 2001 Jan 26; 291(5504):646-50.
[Science. 2001]Science. 2001 Jan 26; 291(5504):650-3.
[Science. 2001]Science. 1995 Dec 8; 270(5242):1671-4.
[Science. 1995]EMBO J. 1999 May 4; 18(9):2522-37.
[EMBO J. 1999]J Biol Chem. 2002 Nov 1; 277(44):41736-43.
[J Biol Chem. 2002]Mol Cell Biol. 2004 Jul; 24(13):6029-39.
[Mol Cell Biol. 2004]Genetics. 2006 Dec; 174(4):1801-10.
[Genetics. 2006]Genetics. 2002 Nov; 162(3):1117-29.
[Genetics. 2002]Mol Cell Biol. 2004 Jul; 24(13):6029-39.
[Mol Cell Biol. 2004]Genetics. 2005 Oct; 171(2):503-15.
[Genetics. 2005]Genetics. 2006 Dec; 174(4):1801-10.
[Genetics. 2006]Methods. 2003 Sep; 31(1):90-5.
[Methods. 2003]Genetics. 2006 Dec; 174(4):1801-10.
[Genetics. 2006]Genetics. 1997 Apr; 145(4):923-34.
[Genetics. 1997]FEMS Yeast Res. 2006 Aug; 6(5):763-76.
[FEMS Yeast Res. 2006]EMBO J. 1999 May 4; 18(9):2522-37.
[EMBO J. 1999]Genetics. 2006 Dec; 174(4):1801-10.
[Genetics. 2006]Science. 1992 Feb 14; 255(5046):817-23.
[Science. 1992]Proc Natl Acad Sci U S A. 1995 Mar 14; 92(6):2224-8.
[Proc Natl Acad Sci U S A. 1995]Genes Dev. 2003 Aug 1; 17(15):1817-22.
[Genes Dev. 2003]Mol Cell Biol. 1997 Dec; 17(12):7159-68.
[Mol Cell Biol. 1997]Mol Cell Biol. 2006 Oct; 26(20):7806-19.
[Mol Cell Biol. 2006]Genetics. 2006 Sep; 174(1):203-13.
[Genetics. 2006]Genetics. 1997 Apr; 145(4):923-34.
[Genetics. 1997]Genetics. 2006 Dec; 174(4):1801-10.
[Genetics. 2006]FEMS Yeast Res. 2006 Aug; 6(5):763-76.
[FEMS Yeast Res. 2006]EMBO J. 1999 Jul 1; 18(13):3808-19.
[EMBO J. 1999]Genes Dev. 2003 Aug 1; 17(15):1817-22.
[Genes Dev. 2003]Mol Cell Biol. 2008 Aug; 28(16):5071-81.
[Mol Cell Biol. 2008]EMBO J. 1999 May 4; 18(9):2522-37.
[EMBO J. 1999]J Biol Chem. 2002 Nov 1; 277(44):41736-43.
[J Biol Chem. 2002]Bioessays. 2004 May; 26(5):523-32.
[Bioessays. 2004]Mol Cell Biol. 2004 Jul; 24(13):6029-39.
[Mol Cell Biol. 2004]Genetics. 2005 Oct; 171(2):503-15.
[Genetics. 2005]Annu Rev Biochem. 2003; 72():481-516.
[Annu Rev Biochem. 2003]Genetics. 2005 Oct; 171(2):503-15.
[Genetics. 2005]Proc Natl Acad Sci U S A. 1997 Apr 1; 94(7):3151-5.
[Proc Natl Acad Sci U S A. 1997]Mol Cell Biol. 2004 Jul; 24(13):6029-39.
[Mol Cell Biol. 2004]J Biol Chem. 2002 Nov 1; 277(44):41736-43.
[J Biol Chem. 2002]Bioessays. 2004 May; 26(5):523-32.
[Bioessays. 2004]Cell. 2002 May 31; 109(5):551-62.
[Cell. 2002]Annu Rev Biochem. 2003; 72():481-516.
[Annu Rev Biochem. 2003]Mol Cell Biol. 2004 Jul; 24(13):6029-39.
[Mol Cell Biol. 2004]J Biol Chem. 2002 Nov 1; 277(44):41736-43.
[J Biol Chem. 2002]Science. 2001 Dec 14; 294(5550):2357-60.
[Science. 2001]Genetics. 2006 Dec; 174(4):1801-10.
[Genetics. 2006]J Cell Sci. 2001 Apr; 114(Pt 8):1447-54.
[J Cell Sci. 2001]Genome Biol. 2004; 5(4):R22.
[Genome Biol. 2004]Annu Rev Biochem. 2003; 72():481-516.
[Annu Rev Biochem. 2003]Bioessays. 2002 Sep; 24(9):828-35.
[Bioessays. 2002]Bioessays. 2004 May; 26(5):523-32.
[Bioessays. 2004]FEMS Yeast Res. 2006 Aug; 6(5):763-76.
[FEMS Yeast Res. 2006]Genetics. 2006 Dec; 174(4):1801-10.
[Genetics. 2006]EMBO J. 1999 Jul 1; 18(13):3808-19.
[EMBO J. 1999]EMBO J. 1999 May 4; 18(9):2538-50.
[EMBO J. 1999]Genetics. 2001 May; 158(1):167-76.
[Genetics. 2001]Mol Cell Biol. 2008 Aug; 28(16):5071-81.
[Mol Cell Biol. 2008]Genes Dev. 2003 Aug 1; 17(15):1817-22.
[Genes Dev. 2003]Bioessays. 2002 Sep; 24(9):828-35.
[Bioessays. 2002]Annu Rev Biochem. 2003; 72():481-516.
[Annu Rev Biochem. 2003]EMBO J. 1999 May 4; 18(9):2538-50.
[EMBO J. 1999]EMBO J. 1999 Jul 1; 18(13):3808-19.
[EMBO J. 1999]Science. 1992 Feb 14; 255(5046):817-23.
[Science. 1992]Proc Natl Acad Sci U S A. 1995 Mar 14; 92(6):2224-8.
[Proc Natl Acad Sci U S A. 1995]EMBO J. 1999 Jul 1; 18(13):3808-19.
[EMBO J. 1999]Genes Dev. 2003 Aug 1; 17(15):1817-22.
[Genes Dev. 2003]Genes Dev. 2003 Aug 1; 17(15):1817-22.
[Genes Dev. 2003]Genome Biol. 2004; 5(4):R22.
[Genome Biol. 2004]Annu Rev Biochem. 2003; 72():481-516.
[Annu Rev Biochem. 2003]Annu Rev Biochem. 2003; 72():481-516.
[Annu Rev Biochem. 2003]Mol Cell Biol. 2004 Jul; 24(13):6029-39.
[Mol Cell Biol. 2004]Genetics. 2005 Oct; 171(2):503-15.
[Genetics. 2005]J Biol Chem. 2003 Jul 25; 278(30):27372-81.
[J Biol Chem. 2003]Genetics. 2006 Dec; 174(4):1801-10.
[Genetics. 2006]